{
  "metadata": {
    "start_date": "2023-01-01",
    "end_date": "2023-12-31",
    "total_signals": 459,
    "companies_analyzed": 50
  },
  "correlations": {
    "7d": 0.7201,
    "30d": 0.504,
    "90d": 0.1773,
    "p_value_30d": 0.0
  },
  "win_rates": {
    "bullish": 0.7929,
    "bearish": 0.7149,
    "overall": 0.7429
  },
  "returns": {
    "bullish_30d": 8.81,
    "bearish_30d": -6.84,
    "neutral_30d": -2.22,
    "by_strength": {
      "strong_bullish (6+)": 12.02,
      "bullish (3-6)": 6.26,
      "weak_bullish (0-3)": 0,
      "weak_bearish (-3-0)": -4.2,
      "bearish (-6--3)": -7.03,
      "strong_bearish (<-6)": -6.2
    }
  },
  "risk_metrics": {
    "sharpe_ratio": -0.3365,
    "max_drawdown": -50.79,
    "volatility": 14.23
  },
  "optimized_weights": {
    "CEO_PURCHASE": 5,
    "CEO_SALE": -4,
    "CFO_PURCHASE": 4,
    "CFO_SALE": -5,
    "CMO_PURCHASE": 5,
    "CMO_SALE": -5,
    "DIRECTOR_PURCHASE": 3,
    "OFFICER_PURCHASE": 3,
    "MULTIPLE_INSIDER_BUY": 5.3,
    "MULTIPLE_INSIDER_SELL": -5.0,
    "FUND_NEW_POSITION": 5,
    "FUND_INCREASE_50": 4,
    "FUND_EXIT": -5,
    "COMMERCIAL_BUILDUP": 5,
    "HIRING_FREEZE": -4
  },
  "weight_improvement": 0.0,
  "summary_by_type": {
    "insider_sell": {
      "count": 319,
      "avg_return_30d": -5.83,
      "win_rate": 0.3,
      "avg_strength": -3.51,
      "best_return": 48.22,
      "worst_return": -50.79
    },
    "insider_buy": {
      "count": 140,
      "avg_return_30d": 8.81,
      "win_rate": 0.79,
      "avg_strength": 5.69,
      "best_return": 54.93,
      "worst_return": -41.9
    }
  },
  "summary_by_sector": {
    "oncology": {
      "count": 60,
      "avg_return_30d": 1.48,
      "win_rate": 0.58,
      "correlation": 0.486
    },
    "gene_therapy": {
      "count": 58,
      "avg_return_30d": -4.65,
      "win_rate": 0.34,
      "correlation": 0.53
    },
    "rare_disease": {
      "count": 43,
      "avg_return_30d": -1.82,
      "win_rate": 0.37,
      "correlation": 0.54
    },
    "cns": {
      "count": 73,
      "avg_return_30d": -1.34,
      "win_rate": 0.41,
      "correlation": 0.511
    },
    "immunology": {
      "count": 38,
      "avg_return_30d": -3.75,
      "win_rate": 0.37,
      "correlation": 0.554
    },
    "large_cap": {
      "count": 72,
      "avg_return_30d": 0.79,
      "win_rate": 0.51,
      "correlation": 0.493
    }
  },
  "recommendations": [
    "MODERATE SYSTEM: Signal correlation of 50.4% shows promise. Consider additional signal refinement.",
    "BULLISH SIGNALS EFFECTIVE: 79% win rate. Focus on strong buy signals (score 6+).",
    "BEARISH SIGNALS EFFECTIVE: 71% win rate. Use sell signals for risk management.",
    "HIGH-CONVICTION BUYS: Strong bullish signals (6+) average 12.0% return. Prioritize these signals.",
    "SECTOR FOCUS: IMMUNOLOGY sector shows highest signal correlation (55%). Consider overweighting this sector.",
    "POSITION SIZING: Scale position size with signal strength. Use 2% base position for score 3-5, 3-4% for score 6+.",
    "RISK MANAGEMENT: Set 10% stop-loss on all signal-based positions. Reduce exposure when multiple bearish signals cluster."
  ]
}